Evidence map›Paper›PMID 32564190›Full record

ArticleEndocrine2020

Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients.

Filippo Ceccato, Laura Lizzul, Mattia Barbot, Carla Scaroni

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Filippo CeccatoEndocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy. filippo.ceccato@unipd.it.ORCID http://orcid.org/0000-0003-1456-8716
Laura LizzulEndocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy.
Mattia BarbotEndocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy.
Carla ScaroniEndocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimA close relationship between adiposity and increased cortisol levels is well established in patients with endogenous hypercortisolism. Nevertheless, hypothalamic-pituitary-adrenal (HPA) axis regulation in overweight subjects is still a matter of concern. We studied free cortisol (urinary free cortisol, UFC and late night salivary cortisol, LNSC), pituitary feedback (serum cortisol after 1 mg dexamethasone suppression test, 1 mg DST) and peripheral cortisol metabolism (urinary cortisol to cortisone ratio, F/E MATERIALS AND

methodsWe considered 234 patients divided in 5 BMI classes, matched for age and gender (BMI ≤ 25 kg/m

resultsWe collected 183 LNSC, 176 UFC, 152 1 mg DST and 64 F/E

conclusionsOverweight and obese subjects are characterised by an original regulation of HPA axis (reduced UFC levels, increased suppression after 1 mg DST) and peripheral cortisol metabolism (reduced F/E

Indexed as

Cushing SyndromeHydrocortisoneDexamethasoneHumansHypothalamo-Hypophyseal SystemObesityPituitary-Adrenal SystemSalivaDexamethasoneHydrocortisoneCortisolCortisol to cortisone ratioDexamethasone suppression testObesityUrinary free cortisol

Identifiers

PMID32564190
OpenAlexW3036570172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.